Ivermectin and Fenbendazole are the two most searched antiparasitic cancer protocol drugs in 2026 — but they work through completely different mechanisms and suit different cancer types. Fenbendazole attacks cancer's structural and metabolic foundations; Ivermectin unmasks cancer cells from the immune system via PD-L1. This complete comparison covers the ICONIC trial update, 716-case series, full protocol frameworks, the cancer-type match guide, price table.